Ramesh Mullangi
5Patents
2h-index
15Co-inventors
44Inventor score
Filing activity: May 24, 2007 → Sep 1, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9896445B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US10471051B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US7601733B2 | 5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US7601732B2 | Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin | Chemistry; Metallurgy | 1 | Active |
| US8080559B2 | 5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.